Week 418 Review - Last week's gains wiped out as Optibiotix drops.

I guess it was too much to hope that the great run would continue, and this week was one of the worst ever weeks, with most of last week's gains being wiped out as OPTI:Optibiotix fell 8p. It was a pretty rotten week across most of the portfolio, with few shares finishing the week better off. The deficit between cost and value widened by £18,397 to £79,289 and total portfolio value dropped to £107,696.

The worst performer was ANTO:Antofagasta, which zoomed upwards early in the week until the day I did my monthly savings transaction, after which it absolutely plummeted leaving me having purchased at the top of the spike. The impact was a 12% drop in value, and I went from being 11% up to 1% down. Just about summed up the week!

RIO:Rio Tinto also struggled, dropping 5% despite announcing lots of exciting new ventures.

The biggest disaster was OPTI:Optibiotix dropping 8p. For my cheapest shares that was a drop of 83%, and even for my most expensive shares it was a drop of 9%.

There was some consolation for some of my other larger holdings, with CAML:Central Asia Metals up 5% after being tipped in a Sunday paper. That was enough to put one of my holdings 2% into profit.

PBX:Probiotix Health climbed 1p, which is 5% for my big dividend holding, and 13% for my more recent cheaper buys.

Share of the Week is SBTX:SkinBioTherapeutics which climbed 11% and begged the question whether people were selling OPTI to buy SBTX?

Here's the ISA and shares portfolio after week 2 of year 9.

			Weekly Change
Cash	£153.80		-£109.89
Portfolio cost	£88,364.43		+£509.89
Portfolio sell value (bid price-commission)	£48,157.05	(-45.5%)	-£8,417.81
Potential profits	£2,912.18		-£2,018.58
Yr 9 Dividends	£0		+£0
Yr 9 Interest	£0		+£0
Yr 9 Profit from sales	£0		+£0
Yr 9 proj avg monthly profit	-£8.15	(-0.2%)	+£8.13
Total Dividends	£11,911.43		+£0
Total Interest	£1.93		+£0
Total Profit from sales	£17,298.53		+£0
Average monthly cash profit	£298.87	(6.0%)	-£0.72
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	48%		+0%

I found £400 down the back of various account's sofas and added it to my ISA along with £100 of dividends transferred from my AJ Bell dealing account. That gave me £500 to buy some more shares. I bought 7,143 shares in JLP:Jubilee Metals at 6.999p costing £509.89 as I think they are ridiculously under priced. That brings the average for my AJ Bell holding down to 7.414p and increases my holding there to 26,703, and my total JLP holding now stands at 143,725. They are losing £5,168 at the moment so a turnaround would have a significant improvement on my overall performance.

The rest of the story is misery as half my potential OPTI:Optibiotix profits are wiped out along with £8,417 portfolio value.

I guess it's not a surprise, but I was hoping for consolidation rather than a big drop.

Still reassuringly high above the trend line which will hopefully flatten out soon.

The SIPP looks like this after week 402 overall and week 38 of year 8.

			Weekly Change
Cash	£152.31		-£232.06
Portfolio cost	£96,247.60		+£232.06
Portfolio sell value (bid price - commission)	£57,842.70	(-39.9%)	-£9,951.22
Potential profits	£4,250.67		-£3,094.23
Yr 8 Dividends	£239.37		+£0
Yr 8 Interest	£3.82		+£0
Yr 8 Profit from sales	-£9,597.85		+£0
Yr 8 proj avg monthly profit	-£1,078.79	(-19.8%)	+£29.15
Total Dividends	£14,382.15		+£0
Total Interest	£4.07		+£0
Total Profit from sales	£10,835.90		+£0
Average monthly cash profit	£260.00	(4.8%)	-£0.65
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	37%		+0%

My monthly savings investment was with ANTO:Antofagasta where I bought 14 shares at 1638.67p costing £232.06 with commission and stamp duty. They immediately fell to 1509p, which I consider a disaster of bad timing. The rest of the story mirrors that of the ISA thanks to the big drop in OPTI:Optibiotix.

It was nice to be above the injection for a short time.

The trend line might be flat by next week unless we plummet again.

The trading account looks like this after week 368 overall and week 4 of year 8.

			Weekly Change
Cash	£273.24		+£0
Portfolio cost	£1,794.51		+£0
Portfolio sell value (bid price - commission)	£1,117.76	(-37.7%)	-£28.47
Potential profits	£0		+£0
Year 8 Dividends	£0		+£0
Year 8 Interest	£0		+£0
Year 8 Profit	£283.99		+£0
Yr 8 proj avg monthly profit	£307.65	(+205.7%)	-£102.55
Dividends	£60.10		+£0
Interest	£0.03		+£0
Profit from sales	-£646.70		+£0
Average monthly cash profit	-£6.91	(-4.6%)	+£0.02
(Sold stocks profit + Dividends - Fees / Months)

Everything dropped this week, so we're back to a familiar pattern for the trading account. My genius purchase of BARC:Barclays has been underwhelming, with them dropping 12% in a few weeks, and my two purchases of JLP:Jubileee Metals are down by 48%. At least I have £273 cash, which I'm half tempted to take out to get the injection line down, but the prospect of only needing £230 profit to enable an additional share to be bought means I'll leave it alone.

I guess that doesn't look too bad compared the the recent past

Right on the trend line, which means we have to go up next week to avoid dipping below it.

OPTI:Optibiotix was bound to drift if there was no news, but I was really hoping there would be news. If none is forthcoming next week there's a risk we'll drift the same amount again and all my optimism would have been a very short-lived spike. The key to maintaining my morale is not to drop more than £7k, as that will take my portfolio value back below £100k and I'll be very sad.

Week 417 Review - Optibiotix rises again to complete the best 3 weeks ever

Yet another amazing week for OPTI:Optibiotix with a 9.5p rise contributing virtually all of the gains, as it was a rubbish week across the rest of the portfolio. The best three weeks ever have all been in the last 3 weeks, with this week being 2nd only to the £32k rise 3 weeks ago. The deficit between cost and value narrowed by a whopping £22,336 to £60,891 and total portfolio value climbed to £125,694, which is £72k more than it was 3 weeks ago.

There were only 2 really bad performers this week, with both EDV:Endeavour Mining and III:3i Group falling 6%. Both were some of my best performing shares, so it's a bit of a concern. III is still 16% in profit despite the drop, but EDV is now at a loss of 13%. I'm tempted to switch my monthly investment to there next week after my last ANTO:Antofagasta purchase takes me to £1,000. My gold exposure isn't as much as I'd like it to be, but there are few quality shares available, and EDV is one of them.

POLY:Polymetal ceased trading on LSE so I checked out the price on AIX where it's currently suspended while the paperwork goes through, and happy to say the $3.76 on there was worth 295p when I updated the spreadsheet, which is 9% higher. It's academic because I can't sell them until they re-list on LSE, which I'm hoping they will do after selling their Russian assets. Meanwhile I'll enjoy the dividend.

Share of the Week for a 3rd week in a row is OPTI:Optibiotix which climbed 11% of purchase price in my 90p holding, but a spectacular 98% in my 9.55p holding to go 282% up. My potential profit from OPTI is now £11,868, but my more expensive holdings are still making a loss of £39,335 so still £27,467 down, but that's a lot more healthy than 3 weeks ago.

Here's the ISA and shares portfolio after week 1 of year 9.

			Weekly Change
Cash	£263.69		+£21.25
Portfolio cost	£87,854.54		+£0
Portfolio sell value (bid price-commission)	£56,064.97	(-36.2%)	+£10,347.06
Potential profits	£4,930.76		+£2,282.86
Yr 9 Dividends	£0		+£0
Yr 9 Interest	£0		+£0
Yr 9 Profit from sales	£0		+£0
Yr 9 proj avg monthly profit	-£16.26	(-0.3%)	-£16.26
Total Dividends	£11,911.43		+£0
Total Interest	£1.93		+£0
Total Profit from sales	£17,298.53		+£0
Average monthly cash profit	£299.59	(6.0%)	-£0.76
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	48%		+0%

Cash went up £21 as I added my feeble £25 premium bond win, but lost £3.75 monthly charges.

Portfolio value up a magnificent £10k and potential profits up £2,282, which is all OPTI:Optibiotix, as my only other profitable share GAW:Games Workshop dropped 4%.

This is the first week of year 9 and unfortunate there was immediately a monthly charge to drag down the projected monthly profit to -£16. Long term profit from sales and dividends is still 6% but there's no sign of selling opportunities in the near future.

Almost up to the injection line, but not quite.

If we stay up here then the trend line will soon be flat

The SIPP looks like this after week 401 overall and week 37 of year 8.

			Weekly Change
Cash	£384.37		+£233.34
Portfolio cost	£96,015.54		+£0
Portfolio sell value (bid price - commission)	£67,561.86	(-29.6%)	+£12,026.69
Potential profits	£7,344.90		+£3,248.54
Yr 8 Dividends	£239.37		+£0
Yr 8 Interest	£3.82		+£0
Yr 8 Profit from sales	-£9,597.85		+£0
Yr 8 proj avg monthly profit	-£1,107.94	(-20.3%)	+£28.77
Total Dividends	£14,382.15		+£0
Total Interest	£4.07		+£0
Total Profit from sales	£10,835.90		+£0
Average monthly cash profit	£260.65	(4.8%)	-£0.83
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	37%		+0%

I added £250 cash ready for my monthly investment, but paid monthly fees so cash only up £233. Portfolio value up a pleasing £12k and potential profits up £3,248, again all thanks to OPTI:Optibiotix as III:3i Group dropped 6% and ANTO:Antofagasta was flat.

Such a relief seeing this one above the injection line, probably due to a higher number of sensible shares in the portfolio.

Another trend line that will hopefully soon flatten out.

The trading account looks like this after week 367 overall and week 3 of year 8.

			Weekly Change
Cash	£273.24		+£0
Portfolio cost	£1,794.51		+£0
Portfolio sell value (bid price - commission)	£1,146.23	(-36.1%)	-£37.21
Potential profits	£0		+£0
Year 8 Dividends	£0		+£0
Year 8 Interest	£0		+£0
Year 8 Profit	£283.99		+£0
Yr 8 proj avg monthly profit	£410.20	(+274.3%)	-£205.10
Dividends	£60.10		+£0
Interest	£0.03		+£0
Profit from sales	-£646.70		+£0
Average monthly cash profit	-£6.93	(-4.6%)	+£0.01
(Sold stocks profit + Dividends - Fees / Months)

The curse of the trading account strikes again, with all shares dropping in value. I'm very, very bad at this.

Slight dip and a hell of a long way to go to turn this mess around. I'd like to think having a small amount in this account is a good lesson in what not to do in my other accounts where this performance would be much more damaging.

Just above the trend line, which given it still points upwards has to be a good thing.

So, after three absolutely amazing weeks what's going to happen next? Given OPTI:Optibiotix has spun out PBX:Probiotix at 21p, then that puts our current share price at the equivalent of 58p prior to the spin-off, which seems fair for where we're at. The main problem is PBX having dropped to 6p, so I would be happy for OPTI to trade in the 30's for a while if PBX could gain some lost ground.

Clearly any positive news on Sweetbiotix or the microbiome modulators could see a re-rate for OPTI, but the risk is new and returning investors get bored and we start drifting downwards again. I really hope we're past that and in more positive territory now, as getting the portfolio value back above £125k has boosted my morale considerably.

Meanwhile my main poor performer is now JLP:Jubilee Metals. I invested £14,335 when I thought the warrant selling had stopped, as I expected a re-rate from 12p to 20p. Instead I got a re-rate from 12p to 7p which is an absolute disaster. 136,582 shares is almost back to what I had last time I took a big position in JLP. At this level I'm very tempted to find a way to buy more, as the copper price is climbing and JLP are producing more and more every week. Work on their northern expansion in Zambia is about to get started, which will see a significant increase in the ability to produce copper, a metal that is going to come under increasing demand. I think I want to buy some more!

Week 416 Review - This week comes 2nd only to last week's best ever week

I posted on Tuesday because I wanted to celebrate the astronomical surge in OPTI:Optibiotix, and although it briefly touched 42p the next morning, the heady heights didn't last and we ended the week on 27.5p. That still gave the 2nd best week ever, with the deficit between cost and value reducing by £18,716 to £83,228 and total portfolio value going above £100k to £103,103.

There was only one share that dropped more than 6%, and that didn't really as I bought BARC:Barclays in my trading account, so the commission and spread contributed to it ending down by 6%.

ANTO:Antofagasta had another good week, climbing 7% to go 11% up. Just 2 weeks until my final purchase so ideally it won't climb too much more just yet.

SBTX:SkinBioTherapeutics went up 2.25p which is a good 9%. Not sure if it was on the back of the OPTI:Optibiotix rise, but nothing else happened that might trigger it.

Similarly, PBX:Probiotix Health climbed 2p which is 9% of my dividend holding IPO price, but 26% up on my later purchases.

OPTI:Optibiotix wins Share of the Week for a 2nd week, climbing 6.9p which is 71% of my cheapest holding price, or 7% of my most expensive holding price. Potential profits are now £6,230 for my cheaper shares, but still 70% down on my most expensive.

Here's the ISA and shares portfolio after week 52 of year 8.

			Weekly Change
Cash	£242.44		-£5.62
Portfolio cost	£87,854.54		+£0
Portfolio sell value (bid price-commission)	£45,717.91	(-58.0%)	+£8,634.88
Potential profits	£2,647.90		+£1,399.42
Yr 8 Dividends	£142.51		+£0
Yr 8 Interest	£1.93		+£0.14
Yr 8 Profit from sales	-£10,795.53		+£0
Yr 8 proj avg monthly profit	-£891.90	(-18.0%)	+£17.01
Total Dividends	£11,911.43		+£0
Total Interest	£1.93		+£0.14
Total Profit from sales	£17,298.53		+£0
Average monthly cash profit	£300.35	(6.0%)	-£0.78
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	48%		+0%

The last week of year 8. Profit this year was a disaster thanks to DDDD:4D Pharma going bust, so the average monthly loss was £891 (18%), making this by far my worst year. It hammered my long term performance too, although that's benefited from the PBX:Probiotix share dividend. Averaging £300 a month over 8 years isn't bad, or at least wouldn't be if the portfolio was breaking even. It's a long way below my 10% target though.

Increase in potential profits is mostly OPTI:Optibiotix, although £214 the profit is GAW:Games Workshop.

On Tuesday we touched the injection line, but now we're a fair way below it.

We're higher than the highest point on the trend line, so I would hope it starts to flatten quite quickly.

The SIPP looks like this after week 400 overall and week 36 of year 8.

			Weekly Change
Cash	£151.03		+£80.33
Portfolio cost	£96,015.54		+£0
Portfolio sell value (bid price - commission)	£55,535.17	(-42.2%)	+£10,135.23
Potential profits	£4,096.36		+£1,817.16
Yr 8 Dividends	£239.37		+£18.44
Yr 8 Interest	£3.82		+£0.33
Yr 8 Profit from sales	-£9,597.85		+£0
Yr 8 proj avg monthly profit	-£1,136.71	(-20.9%)	+£34.69
Total Dividends	£14,382.15		+£18.44
Total Interest	£4.07		+£0.33
Total Profit from sales	£10,835.90		+£0
Average monthly cash profit	£261.48	(4.8%)	-£0.46
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	37%		+0%

Cash went up thanks to a tax rebate and £18 dividend from III:3i Group. Huge £10k rise in portfolio value and potential profits up mainly due to OPTI:Optibiotix, but also ANTO:Antofagasta now in profit by £78 and III:3i Group in profit by £219.

This one is a lot closer to the injection line, A whole year of decline has been reversed in 2 weeks.

As with the ISA, if the price doesn't drop back, then the trend line should flatten quickly.

The trading account looks like this after week 366 overall and week 2 of year 8.

			Weekly Change
Cash	£273.24		+£252.98
Portfolio cost	£1,794.51		+£31.01
Portfolio sell value (bid price - commission)	£1,183.44	(-34.1%)	-£53.41
Potential profits	£0		-£13.38
Year 8 Dividends	£0		+£0
Year 8 Interest	£0		+£0
Year 8 Profit	£283.99		+£283.99
Yr 8 proj avg monthly profit	£615.30	(+411.5%)	+£615.30
Dividends	£60.10		+£0
Interest	£0.03		+£0
Profit from sales	-£646.70		+£283.99
Average monthly cash profit	-£6.94	(-4.6%)	+£3.40
(Sold stocks profit + Dividends - Fees / Months)

I sold my 2,469 shares in OPTI:Optibiotix at 31.56p and made £283.98 (57.3%) profit. At the time I regretted not waiting, as it was 37p later in the day, but ended the week 4p down on what I sold at, so mustn't grumble. It means there's half the cash I need to buy another share and get back to 5 in this portfolio, and it reduces the long-term losses by £3 a month to £6.

I bought 317 shares in BARC:Barclays as their share price had plummeted despite reasonable results. I was hoping they would bounce back on the day I bought them, but they didn't, in fact they dropped further from where I bought them. If I hold them for a few weeks I'll get a small interim dividend of about £3, but I hope I don't keep them that long as I'm rather eager for the trading account to work like it's meant to.

Getting closer to cost price, but still £1k down on injection amount, so this account is still a disaster.

Good news that we stay above the trend line despite cashing in some profit.

It's difficult to know if the surge in OPTI:Optibiotix share price will continue or stall. If we can keep some momentum of news flow then maybe there's a chance of sustaining the recovery. Otherwise boredom may set in and we go back to our 2-year long drift.

Optibiotix has gone completely mad!

I had to write a mid-week blog post as it might all go south tomorrow and I wanted to register the two best ever days in my portfolio.

There must be institutions buying OPTI:Optibiotix, because the trading amounts are colossal. 8.5 million shares today, and it's been similar every day since last Wednesday.

Today they went up 10.5p from 27p to 37.5p

I've made up £43,798 of losses in 2 days this week, and £32,195 last week. That's £75k in 5 trading days.

The trigger was the RNS last Wednesday which was the first time major global corporate partners were mentioned in connection with Sweetbiotix, these being Kelloggs, Nestle, Coca Cola , Firmenich, Tereos, Cargill, Arla ,Tate and Lyle, Agropur, Givaudan and Tata.

Add to that scares on the health damage of sucralose and aspartame, and it seems to have created a perfect storm.

Volumes have been massive, so surely this must be institutional investors? Given it requires less than 3 million shares to need to declare a holding, will we see any announcements this week?

My OPTI:Optibiotix holding is 241,175 shares costing £116,655, so my average purchase price is around 48p.

I only need the same price rise as happened today to happen again before the end of the week, and my OPTI holding will be in profit.

As it is, I have the purchases split into price bands that I paid for them, so although I'm still £26k down altogether, I have some holdings in profit which are £12,218 up at the moment.

I did sell my trading pot at 31.56p which turns out to be way too early, but it made £283 (57%) profit which is more than my trading account usually makes. Haven't a clue what to buy with it next.

I'm writing this today because I'm very, very happy. I may not be so happy by Friday if there's a re-trace, so I want to write nice words, as there have been 2 years of solid misery, and this is the moment I've been hoping for, for a very long time.

The effect on my portfolio has been to increase the value to £128,110 and reduce the deficit between cost and value to £58,146. 

I'm going to celebrate with a bottle of wine this evening, and I have a day off tomorrow so I can get well away from a computer screen in case it all goes downhill...

Week 415 Review - Best week ever as Optibiotix goes berserk!

What a week! An RNS from OPTI:Optibiotix finally listed the major global corporates we're working with on Sweetbiotix, and the share price rocketed. The result was a reduction in the deficit between cost and value of a record £32,195 to £101,944 and an increase in portfolio value to £84,027.

It was a great week all round, with no big losers at all.

IGG:IG Group posted a good trading update and went up 5%, although I was hoping for a bit more. They are still 19% down but I've had £101 dividends from them and will continue to hold in anticipation of a future re-rate.

PSN:Persimmon went up 7% for the second week in a row, buoyed by lower than expected inflation and the hope mortgage rates will stop rising.

PBX:Probiotix Health went up for the first time since the lock-in period ended. It was only 1p but that was 5% in my main holding and 12% for my recent purchases.

Share of the Week by absolutely miles was OPTI:Optibiotix which went from 7.8p bid price last week to 20.6p this week, a rise of 12.8p. That's more than double! The percentage increase varied between my highest price holding bought for 90p which climbed 14%, to my recent purchases averaging 9.55p which went up 133%.

Here's the ISA and shares portfolio after week 51 of year 8.

			Weekly Change
Cash	£248.06		+£10.73
Portfolio cost	£87,854.54		+£499.97
Portfolio sell value (bid price-commission)	£37,083.03	(-57.8%)	+£14,610.60
Potential profits	£1,248.48		+£1,095.26
Yr 8 Dividends	£142.51		+£10.70
Yr 8 Interest	£1.79		+£0
Yr 8 Profit from sales	-£10,795.53		+£0
Yr 8 proj avg monthly profit	-£908.91	(-18.3%)	+£19.10
Total Dividends	£11,911.43		+£10.70
Total Interest	£1.79		+£0
Total Profit from sales	£17,298.53		+£0
Average monthly cash profit	£301.13	(6.1%)	-£0.62
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	48%		-1%

I got a £10 dividend from PLUS:Plus500 and also added £500 which I intended to use to buy PBX:Probiotix Health, but AJ Bell wouldn't let me buy them despite it being ok a few weeks ago. It sounds like lots of people have had trouble buying the shares, so the Aquis exchange is clearly not fit for purpose and these need to be listed on AIM.

Instead I bought another 6,471 shares in JLP:Jubilee Metals at 7.5725p costing £499.97. They promptly dropped to 7.4p. I'm surprised, as they gave a pretty good trading statement this week.

Portfolio value rocketed by £14,610 mainly thanks to OPTI:Optibiotix, but it's still 57% down so there's a long way to go. However, now I've split my OPTI:Optibiotix holding into shares bought at 10p intervals, the holding bought for an average of 15p went £1,065 into profit, and with an increase in GAW:Games Workshop, potential profits rose £1,095.

Almost halved the distance back to the injection line, and no need to lower the Y axis any more.

That's more like it - much higher than the trend line - lets hope we can drag it back up.

The SIPP looks like this after week 399 overall and week 35 of year 8.

			Weekly Change
Cash	£70.70		+£0
Portfolio cost	£96,015.54		+£0
Portfolio sell value (bid price - commission)	£45,399.94	(-52.7%)	+£17,291.36
Potential profits	£2,279.20		+£2,067.76
Yr 8 Dividends	£220.93		+£0
Yr 8 Interest	£3.49		+£0
Yr 8 Profit from sales	-£9,597.85		+£0
Yr 8 proj avg monthly profit	-£1,171.40	(-21.6%)	+£34.45
Total Dividends	£14,363.71		+£0
Total Interest	£3.74		+£0
Total Profit from sales	£10,835.90		+£0
Average monthly cash profit	£261.94	(4.8%)	-£0.66
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	37%		+0%

Fairly quiet, except for the stonking £17,291 rise in value and my 9.5p OPTI:Optibiotix holding going £1,955 into profit, my 18.2p holding going £17 into profit and my 18.88p holding going £77 into profit, all helping potential profits rise by £2,067.

I reckon that has pretty much halved the distance to the injection line

A glorious sight.

The trading account looks like this after week 365 overall and week 1 of year 8.

			Weekly Change
Cash	£20.26		+£0
Portfolio cost	£1,763.50		+£0
Portfolio sell value (bid price - commission)	£1,205.84	(-31.6%)	+£293.78
Potential profits	£13.38		+£13.38
Year 8 Dividends	£0		+£0
Year 8 Interests	£0		+£0
Year 8 Profit	£0		+£0
Yr 8 proj avg monthly profit	£0	(+0%)	+£0
Dividends	£60.10		+£0
Interest	£0.03		+£0
Profit from sales	-£930.69		+£0
Average monthly cash profit	-£10.34	(-7.0%)	+£0.02
(Sold stocks profit + Dividends - Fees / Months)

What a way to start the new year for this account. Not only do I lose the miserable negative stats suffered from the Year 7 DDDD:4D Pharma collapse, but OPTI:Optibiotix drags the value up by £293 and goes £13 into profit. Surely I won't actually get to sell a share in my trading account?!

It doesn't look as impressive when you see how far it needs to go to get back to the injection line.

Much relief as we go back above the trend line.

I guess there is a risk this week will be a blip and OPTI:Optibiotix will sink again, but I think the market finally recognises that Sweetbiotix is going to happen fairly soon. Launches may be a while off, but companies will need to buy the product long before that, so the key announcements will be around contract signing. One big global contract should see all my losses wiped out. Hope has definitely been re-kindled.

Week 414 Review - Recent gains destroyed as we hit a new all-time low

Absolute misery as OPTI:Optibiotix drops again causing the deficit between cost and value to widen by £2,703 to £134,140, which is a new all-time worst deficit. Portfolio value dropped to £50,993. If it had gone below £50k I may have just jacked the whole thing in.

OPTI:Optibiotix only dropped 1.3p, but for some of my recent purchases that was 10%, and the shares I bought only last week dropped 14%. Every time I buy some more, the price drops. It's been happening for years from 90p all the way down to below 10p.

The rest of the portfolio had quite a good week.

RIO:Rio Tinto and WHR:Warehouse REIT both recovered from recent poor spells by increasing 5%, and PAGE:Page Group rose 6% and is now only 7% down.

PSN:Persimmon went up 7% but is still 27% down.

Share of the Week is ANTO:Antofagasta which went up 10% but I don't really know why. They are back in profit and 4% up, so clearly it's time for my monthly investment. My August purchase will be the last one, then I'll have to find a new magic formula share to buy every month.

Here's the ISA and shares portfolio after week 50 of year 8.

			Weekly Change
Cash	£237.33		-£14.22
Portfolio cost	£87,354.57		+£0
Portfolio sell value (bid price-commission)	£21,972.46	(-74.8%)	-£1,357.81
Potential profits	£153.22		+£29.70
Yr 8 Dividends	£131.81		+£0
Yr 8 Interest	£1.79		+£0
Yr 8 Profit from sales	-£10,795.53		+£0
Yr 8 proj avg monthly profit	-£928.01	(-18.8%)	+£18.94
Total Dividends	£11,900.73		+£0
Total Interest	£1.79		+£0
Total Profit from sales	£17,298.53		+£0
Average monthly cash profit	£301.75	(6.1%)	-£0.73
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	49%		+0%

Cash dropped because I did a re-set. Usually I add and subtract income and expenditure, but clearly I occasionally forget because I was £14 out and had to do a correction.

Portfolio value dropped by £1,357 and is very nearly 75% down

Follow that trend line!

The SIPP looks like this after week 398 overall and week 34 of year 8.

			Weekly Change
Cash	£70.70		-£195.17
Portfolio cost	£96,015.54		+£241.14
Portfolio sell value (bid price - commission)	£28,108.58	(-70.7%)	-£1,313.99
Potential profits	£211.44		+£67.19
Yr 8 Dividends	£220.93		+£0
Yr 8 Interest	£3.49		+£0
Yr 8 Profit from sales	-£9,597.85		+£0
Yr 8 proj avg monthly profit	-£1,205.85	(-22.2%)	+£35.35
Total Dividends	£14,363.71		+£0
Total Interest	£3.74		+£0
Total Profit from sales	£10,835.90		+£0
Average monthly cash profit	£262.60	(4.8%)	-£0.76
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	37%		+0%

Portfolio cost went up as I bought my monthly 17 shares in ANTO:Antofagasta at 1402.6447p costing £241.14 with commission and stamp duty. As with the ISA the portfolio value dropped by over £1k but at least potential profits increased by 67.

Misery.

The trading account looks like this after week 364 overall and week 52 of year 7.

			Weekly Change
Cash	£20.26		+£0
Portfolio cost	£1,763.50		+£0
Portfolio sell value (bid price - commission)	£912.06	(-48.3%)	-£32.09
Potential profits	£0		+£0
Year 7 Dividends	£0.00		+£0
Year 7 Interests	£0.03		+£0
Year 7 Profit	-£1,157.99		+£0
Yr 7 proj avg monthly profit	-£96.44	(-65.6%)	+£1.89
Dividends	£60.10		+£0
Interest	£0.03		+£0
Profit from sales	-£930.69		+£0
Average monthly cash profit	-£10.36	(-7.1%)	+£0.03
(Sold stocks profit + Dividends - Fees / Months)

Last week's gains were wiped out and all is bleak and horrible

Let's get this horrible week saved and posted so we can welcome Week 415 with open arms...

Week 413 Review - Optibiotix continues to recover

A rare 2nd positive week in a row as OPTI:Optibiotix increased again, improving the deficit between cost and value by £1,962 to £131,436, and total portfolio value increased to £53,455.

Not a great week for some magic formula shares, with both IGG:IG Group and III:3i Group dropping 5% for no apparent reason.

OPTI:Optibiotix wins Share of the Week, which is a rare occurrence, with a 7% increase in one of my holdings, but that's my best one and is still down 40%. Most of my holdings are down between 75% and 90%.

Here's the ISA and shares portfolio after week 49 of year 8.

			Weekly Change
Cash	£251.55		+£11.92
Portfolio cost	£87,354.57		+£0
Portfolio sell value (bid price-commission)	£23,330.27	(-73.3%)	+£1,287.46
Potential profits	£123.52		-£14.30
Yr 8 Dividends	£131.81		+£11.64
Yr 8 Interest	£1.79		+£0.28
Yr 8 Profit from sales	-£10,795.53		+£0
Yr 8 proj avg monthly profit	-£946.95	(-19.2%)	+£20.81
Total Dividends	£11,900.73		+£11.64
Total Interest	£1.79		+£0.28
Total Profit from sales	£17,298.53		+£0
Average monthly cash profit	£302.48	(6.1%)	-£0.61
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	49%		+0%

The £11 dividend was from WHR:Warehouse REIT, and 28p interest was a thrill. Portfolio value went up by £1,287 but is still 73% down, and potential profits dropped by £14. Long term performance of 6.1% is 4% down on target, but it doesn't really mean anything when the portfolio value has dropped so much.

A slight tick up but still in danger of needing to adjust the Y axis lower. 

It's nice to have been above the trend line for some time now, but not enough to change it's direction.

The SIPP looks like this after week 397 overall and week 33 of year 8.

			Weekly Change
Cash	£265.87		-£145.27
Portfolio cost	£95,774.40		+£923.42
Portfolio sell value (bid price - commission)	£29,181.43	(-69.5%)	+£640.48
Potential profits	£144.25		-£272.55
Yr 8 Dividends	£220.93		+£0
Yr 8 Interest	£3.49		+£0.88
Yr 8 Profit from sales	-£9,597.85		+£222.31
Yr 8 proj avg monthly profit	-£1,241.20	(-22.9%)	+£69.01
Total Dividends	£14,363.71		+£0
Total Interest	£3.74		+£0.88
Total Profit from sales	£10,835.90		+£222.31
Average monthly cash profit	£263.36	(4.8%)	+£1.77
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	37%		+0%

I know I have vowed never to buy any more OPTI:Optibiotix shares, but I can't stand by while people hoover them up at these prices, so I did buy some more this week. I added £360 to my SIPP to go with some dividend cash and bought 5,407 shares at 9.14p costing £506.15.

Then I decided I couldn't be bothered waiting for NUM:Numis Corp to get taken over, as the share price has stagnated and there's only one small dividend to come. I sold my 374 shares for 332.5802p making £222.30 (21.7%) profit and liberating £1,231.90. I used that to buy 12,525 shares in OPTI:Optibiotix at 9.74p costing £1,231.89.

This caused potential profits to drop by £272 as III:3i Group dropped 5% to add to the cashing in of £222 profit. Value went up by £640.

Again a very slight tick up but a long, long way below the injection line.

This account has been bumping along the trend line rather than just above it.

The trading account looks like this after week 363 overall and week 51 of year 7.

			Weekly Change
Cash	£20.26		+£0
Portfolio cost	£1,763.50		+£0
Portfolio sell value (bid price - commission)	£944.15	(-46.5%)	+£34.57
Potential profits	£0		+£0
Year 7 Dividends	£0.00		+£0
Year 7 Interests	£0.03		+£0
Year 7 Profit	-£1,157.99		+£0
Yr 7 proj avg monthly profit	-£98.33	(-66.9%)	+£1.97
Dividends	£60.10		+£0
Interest	£0.03		+£0
Profit from sales	-£930.69		+£0
Average monthly cash profit	-£10.39	(-7.1%)	+£0.03
(Sold stocks profit + Dividends - Fees / Months)

The increase in OPTI:Optibiotix gave this a little boost, but we're still a long way from being able to sell anything.

Still looks pretty bad.

Below the trend line, which is bad.

I'm 2 weeks behind so on a bit of a catch-up, and eager to post this week and next because Week 415 has just been very interesting!